Another one: NYT now covering the broader GLP-1 effects we've been discussing

Not long ago I posted about GLP-1s having direct immune effects beyond weight loss, then the BMJ addiction study dropped and added another layer to that story. Now the New York Times ran a big opinion piece called "The Great American GLP-1 Experiment" covering basically the same territory: people using GLP-1s and noticing effects on arthritis, migraines, addiction, inflammation, all outside the original indications.

Worth a read, but if you've been following along here none of it will surprise you. The anecdotal signal was showing up long before the research caught up, and the research was showing up long before the mainstream press noticed.

The thing that stuck with me: roughly 1 in 8 American adults is currently on a GLP-1. That's a massive real-world experiment running whether the medical establishment is ready for it or not. The immuno-metabolic angle we talked about in that first post is quietly becoming harder to ignore.

https://www.nytimes.com/interactive/2026/04/15/opinion/glp1-health-effects.html

View more stories at r/PeptideTides

Posted Apr 27, 2026, 12:27 PM UTC

122
Loading comments…